glp-1 agonists cardiovascular diseases receptor (GLP-1RAs): actions and therapeutic potential Frontiers | Glucagon-like peptide-1 receptor
Description
Linge J, Birkenfeld AL, Neeland IJ
No pancreatic safety concern following glucagon-like peptide-1 receptor agonist therapies: a pooled analysis of cardiovascular outcome trials
Clin Drug Investig
This hormone performs several crucial roles to support weight management: Appetite Regulation: It targets areas of the brain that control hunger, effectively turning down the food noise and reducing cravings
GLP-1 drug therapy helps in multiple ways: Improves insulin production when blood sugar is high Reduces the release of glucagon, a hormone that increases blood sugar Slows down gastric emptying, making you feel full for longer Reduces appetite, leading to fewer calorie intakes These combined effects make GLP-1 agonists powerful tools for diabetes weight control
Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes
